Singaporean therapy firm Tessa Therapeutics raises $126 million in Series A round
Tessa Therapeutics, a therapy firm based in Singapore has raised $126 million in its Series A round to support the development of immune cell therapies for cancer.
* The funds will help the firm to scale its cancer therapy development including the clinical trial of the TT11 programme and TT11x programme.